NCT06655311: A Study of Enlicitide Chloride (MK-0616) in Healthy Participants and Participants Taking Statins (MK-0616-012)
- State
- Completed
- Phase
- Phase 1
- People
- 56 taking part
- Started
- 30 Sep 2022
- Primary completion
- 2 Jan 2024
- Arms
- Enlicitide Chloride
- Results
- None posted
- 30 Sep 2022: Trial started
- 2 Jan 2024: Trial completed
- 23 Oct 2024: Trial registered